NEWPORT NEWS, Va. — October 13, 2024 — ivWatch, LLC, the IV safety company, today unveiled a packed lineup of fall conference exhibitions, including the American Society of Anesthesiologists (ASA) in Philadelphia, Pennsylvania; Global Health Exhibition/Invest in Health in Riyadh, Saudi Arabia; American Nurses Credentialing Center’s (ANCC) National Magnet & Pathway to Excellence Conferences in New Orleans, Louisiana; and MEDICA in Dusseldorf, Germany.
People often think, “It’s just an IV. It’s routine, it’s perfectly safe.” But the reality is that two billion IVs are administered globally each year and half of them fail. Just ask Melissa Williams, who late last month, along with ivWatch, bravely told her extravasation journey to vascular access experts.
These life altering extravasations are significant and preventable. ivWatch will be issuing warnings to clinicians and vascular experts of the severe dangers, including medical dosing errors, that can occur from extravasations when administering IV therapy.
Along with calling attention to these warnings, ivWatch will be providing live product demonstrations showcasing its continuous IV monitoring technology on site. ivWatch invites you to join them to share your IV therapy experiences and discuss proactive protocols as well as solutions available to prevent severe patient injuries.
Details of upcoming conferences at which ivWatch will have a presence include:
ASA – American Society of Anesthesiologists
Pennsylvania Convention Center, Philadelphia, October 19-21 – Booth 6049
Global Health Exhibition/Invest in Health
Malham, Riyadh, Saudi Arabia, October 21-24 – Booth UK Pavilion, Hall 1- H1C‐Y91
ANCC National Magnet & Pathway to Excellence Conferences
Ernest N. Morial Convention Center, New Orleans, October 30 – November 1st – Booth 157
Messe Dusseldorf, Germany, November 11-14 – Hall 15 ABHI UK Pavilion, Stand #15A24.6
Attendees can discuss their IV therapy challenges and programs to improve patient safety and decrease IV complications. Many hospitals are utilizing ivWatch as part of quality improvement projects, including those for magnet submissions.
To learn more about the ivWatch patient monitoring system for IV infiltrations and extravasations visit: https://www.ivwatch.com/tech-overview/.
About ivWatch, LLC
ivWatch, LLC is a biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is pioneering the use of optical sensors to detect adverse IV events early to minimize the risk of injury caused by infiltrations and extravasations. By using this technology, clinicians can leverage continuous monitoring to help identify infiltrations as early as possible. Our innovative IV monitoring solutions are backed by decades of clinical research and device development. To learn more, follow us on Twitter @ivWatch, Facebook @ivWatchLLC, Instagram @ivWatchLLC and LinkedIn @ivWatch-LLC, or visit www.ivWatch.com.